Back
Day One Biopharmaceuticals, Inc. Vs. Citi Trends, Inc. Industry Stock Comparison
Sell
45
DAWN
Day One Biopharmaceuticals, Inc.
Last Price:
$21.46
Seasonality Move:
-4.61%
Sell
42
CTRN
Citi Trends, Inc.
Last Price:
$43.28
Seasonality Move:
12.11%
Sell
45
Day One Biopharmaceuticals, Inc. (DAWN)
is a Sell
Is Day One Biopharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Day One Biopharmaceuticals, Inc. [DAWN] share price is $21.45. The Score for DAWN is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
DAWN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Citi Trends, Inc. (CTRN)
is a Sell
Is Citi Trends, Inc. a Buy, Sell or Hold?
-
The current Citi Trends, Inc. [CTRN] share price is $43.37. The Score for CTRN is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
CTRN is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAWN Stock Price Chart
What is Day One Biopharmaceuticals, Inc.'s stock price today?
-
The Day One Biopharmaceuticals, Inc. share price today is $21.45Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DAWN is experiencing slight buying pressure.
CTRN Stock Price Chart
What is Citi Trends, Inc.'s stock price today?
-
The Citi Trends, Inc. share price today is $43.37Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTRN is experiencing buying pressure, which is a positive indicator for future bullish movement.
DAWN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.84 | Buy |
| Relative Strength Index (14 RSI): | 81.38 | Buy |
| Chaikin Money Flow: | 280617 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.3 - 23.4) | Buy |
| Bollinger Bands (100): | (7.69 - 17.01) | Buy |
CTRN Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.86 | Sell |
| Relative Strength Index (14 RSI): | 45.24 | Sell |
| Chaikin Money Flow: | 23006 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.39 - 48.47) | Sell |
| Bollinger Bands (100): | (41.74 - 47.08) | Sell |
DAWN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.41 | Buy |
| 20-day SMA: | 21.35 | Buy |
| 50-day SMA: | 15.42 | Buy |
| 200-day SMA: | 9.68 | Buy |
| 8-day EMA: | 21.35 | Buy |
| 20-day EMA: | 20.03 | Buy |
| 50-day EMA: | 16.62 | Buy |
| 200-day EMA: | 11.56 | Buy |
CTRN Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.25 | Buy |
| 20-day SMA: | 45.56 | Sell |
| 50-day SMA: | 45.33 | Sell |
| 200-day SMA: | 38.71 | Buy |
| 8-day EMA: | 43.72 | Sell |
| 20-day EMA: | 44.81 | Sell |
| 50-day EMA: | 45.04 | Sell |
| 200-day EMA: | 39.29 | Buy |
Day One Biopharmaceuticals, Inc. Earnings Growth & DAWN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.16 per share, and an increase next year of $0.71 per share.
Citi Trends, Inc. Earnings Growth & CTRN Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.59 per share, an increase next quarter of $1.11 per share, an increase this year of $2.10 per share, and an increase next year of $1.84 per share.
Day One Biopharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Citi Trends, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||